11:42 AM EST - Response Biomedical Corp. : Has entered into a definitive arrangement agreement with 1077801 B.C. Ltd., a company owned by OrbiMed Asia Partners, LP, OrbiMed Private Investments III, LP and OrbiMed Associates III, LP and Shanghai Runda Medical Technology Co., Ltd. pursuant to which 1077801 B.C. Ltd. will acquire all of the issued and outstanding common shares of Response for cash consideration of $1.12 per Response Share. Response Biomedical Corp.
shares T.RBM are trading up $0.30 at $1.04.
